Actinium Pharmaceuticals
ATNM
#10426
Rank
NZ$47.2 M
Marketcap
NZ$1.50
Share price
-4.22%
Change (1 day)
-46.85%
Change (1 year)

Market capitalization of Actinium Pharmaceuticals (ATNM)

Market cap: NZ$47.2 Million

As of July 2026 Actinium Pharmaceuticals has a market cap of NZ$47.2 Million. This makes Actinium Pharmaceuticals the world's 10426th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Actinium Pharmaceuticals from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$47.2 M-42.34%
2025NZ$81.87 M23.35%
2024NZ$66.37 M-69.86%
2023NZ$0.22 B-48.48%
2022NZ$0.42 B119.39%
2021NZ$0.19 B2.8%
2020NZ$0.18 B256.01%
2019NZ$53.23 M-20.25%
2018NZ$66.75 M-10.72%
2017NZ$74.77 M6.18%
2016NZ$70.41 M-66.14%
2015NZ$0.20 B-7.7%
2014NZ$0.22 B27.96%
2013NZ$0.17 B351.41%
2012NZ$39 M2380.93%
2011NZ$1.57 M

End of Day market cap according to different sources

On Jul 20th, 2026 the market cap of Actinium Pharmaceuticals was reported to be:

NZ$47.21 Million
by Nasdaq info icon info icon
NZ$47.2 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
NZ$0.01 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$7.75 B 16,323.08%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$19.46 B 41,139.51%๐Ÿ‡บ๐Ÿ‡ธ USA